Filters
Use basic filters below or open advanced options for more precise results.
Last dataset refresh: 05 Apr 2026
| Product name | Classification | Strength | Form | Manufacturer | Country of origin | Status | Registered On | Action | |
|---|---|---|---|---|---|---|---|---|---|
|
Vancomicina Azevedos 500 mg
|
Conventional Medicines | 500 mg/Vial | Infusion | SOFARIMEX - INDUSTRIA QUIMICA E FARMACEUTICA, S.A, Portugal, Cacem | Portugal | Active | 12 May 2016 | View details → | |
|
VANCOTEX 500 mg
|
Conventional Medicines | 500mg/Vial | Infusion and Oral Solution | Fisiopharma Srl, Italy, Palomonte | Italy | Active | 23 Jan 2023 | View details → | |
|
Vanguard 160 mg
|
Conventional Medicines | 160 mg/tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 03 Jun 2012 | View details → | |
|
Vanguard 320 mg
|
Conventional Medicines | 320 mg/tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Navarre | Spain | Active | 03 Jun 2012 | View details → | |
|
Vanguard 40 mg
|
Conventional Medicines | 40 mg/tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 03 Jun 2012 | View details → | |
|
Vanguard 80 mg
|
Conventional Medicines | 80 mg/tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 03 Jun 2012 | View details → | |
|
Vanguard CCB 10/160 mg
|
Conventional Medicines | 10 mg/160 mg/Tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 30 Jun 2022 | View details → | |
|
Vanguard CCB 5/160 mg
|
Conventional Medicines | 5 mg/160 mg/Tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 30 Jun 2022 | View details → | |
|
Vanguard CCB 5/80 mg
|
Conventional Medicines | 5 mg/80 mg/Tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 30 Jun 2022 | View details → | |
|
Vanguard CCB Plus 10/160/12.5 mg
|
Conventional Medicines | 10 mg/160 mg/12.5 mg/Tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 18 May 2022 | View details → | |
|
Vanguard CCB Plus 10/160/25 mg
|
Conventional Medicines | 10 mg/160 mg/25 mg/Tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 18 May 2022 | View details → | |
|
Vanguard CCB Plus 5/160/12.5 mg
|
Conventional Medicines | 5 mg/160 mg/12.5 mg/Tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 18 May 2022 | View details → | |
|
Vanguard CCB Plus 5/160/25 mg
|
Conventional Medicines | 5 mg/160 mg/25 mg/Tablet | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 18 May 2022 | View details → | |
|
Vanguard Plus 80 mg/12.5 mg
|
Conventional Medicines | Combination | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 03 Jun 2012 | View details → | |
|
Vanguard Plus 160 mg/12.5 mg
|
Conventional Medicines | Combination | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 03 Jun 2012 | View details → | |
|
Vanguard Plus 160 mg/25 mg
|
Conventional Medicines | Combination | Tablet | LABORATORIOS CINFA S.A, Spain, Areta Huarte | Spain | Active | 03 Jun 2012 | View details → | |
|
VANRAFIA™ 0.75 mg
|
Conventional Medicines | 0.75 mg/Tablet | Tablet | Novartis Pharmaceutical Manufacturing LLC , Slovenia, 1000 Ljubljana | United States of America | Active | 14 Apr 2025 | View details → | |
|
VANTICO 500 mg/Vial
|
Conventional Medicines | 500mg/Vial | Injection | MicroSynergy Pharmaceuticals, United Arab Emirates, Dubai | United Arab Emirates | Active | 07 Oct 2021 | View details → | |
|
VANTICO 500 mg/Vial
|
Conventional Medicines | 500mg/Vial | Injection | MicroSynergy Pharmaceuticals, United Arab Emirates, Dubai | United Arab Emirates | Active | 07 Oct 2021 | View details → | |
|
Vantra® 100 mg
|
Conventional Medicines | 100 mg/Tablet | Tablet | SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO ADDWAEH), Saudi Arabia, Burayadh-Ind. City, Al-Qassim | Saudi Arabia | Active | 20 May 2024 | View details → | |
|
Vantra® 200 mg
|
Conventional Medicines | 200 mg/Tablet | Tablet | SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO ADDWAEH), Saudi Arabia, Burayadh-Ind. City, Al-Qassim | Saudi Arabia | Active | 20 May 2024 | View details → | |
|
VAPRENA® 15 mg
|
Conventional Medicines | 15 mg/Tablet | Tablet | SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO ADDWAEH), Saudi Arabia, Burayadh-Ind. City, Al-Qassim | Saudi Arabia | Active | 14 Nov 2022 | View details → | |
|
VAPRENA® 30 mg
|
Conventional Medicines | 30 mg/Tablet | Tablet | SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES CORPORATION (SPIMACO ADDWAEH), Saudi Arabia, Burayadh-Ind. City, Al-Qassim | Saudi Arabia | Active | 14 Nov 2022 | View details → | |
|
VAQTA ® 50 U/ml VACCINE
|
Biological Medicines | 50 U / 1.0ml | Injection | MERCK SHARP & DOHME B.V., Netherlands, Haarlem | United States of America | Active | 06 Dec 1999 | View details → |
Compare selected products
0 of 3 selected